Regenxbio (RGNX) Interest Expenses (2014 - 2026)

Regenxbio's Interest Expenses history runs 12 years deep, the most recent figure standing at -$147.5 million for Q4 2025.

• In Q4 2025, Interest Expenses fell 1616.32% year-over-year to -$147.5 million; the TTM figure through Dec 2025 stood at -$114.8 million (down 9143.34% YoY), while the FY2025 annual figure was $374.4 million, up 10.66% from the prior year.
• Interest Expenses for Q4 2025 stood at -$147.5 million, down from $13.2 million in the prior quarter.
• The five-year high for Interest Expenses was $74.1 million in Q3 2021, with the low at -$147.5 million in Q4 2025.
• The 5-year median for Interest Expenses is $10.3 million (2023), against an average of $10.5 million.
• Peak annual rise in Interest Expenses reached 913.0% in 2025, while the deepest fall reached 1616.32% in 2025.
• Regenxbio's Interest Expenses stood at $6.5 million in 2021, then plunged by 303.8% to -$13.2 million in 2022, then jumped by 152.93% to $7.0 million in 2023, then surged by 38.74% to $9.7 million in 2024, then plunged by 1616.32% to -$147.5 million in 2025.
• Business Quant data shows RGNX's Interest Expenses at -$147.5 million in Q4 2025, $13.2 million in Q3 2025, and $11.0 million in Q2 2025.